This trial is testing a combined community health worker and smartphone intervention linked to a smart pill box for antiretroviral adherence in HIV positive people in the United States. The goal is to see if this intervention enables people to self-manage their antiretroviral regimens while CHW monitor their adherence in real-time, ultimately leading to viral suppression and adherence.
1 Primary · 2 Secondary · Reporting Duration: 6 month follow up, 12 month follow up
2 Treatment Groups
1 of 2
1 of 2
300 Total Participants · 2 Treatment Groups
Primary Treatment: CHW Sessions · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there currently any additional participants sought for this experiment?
"Affirmative. The clinical trial portal, clinicaltrials.gov, reveals that enrollment for this medical trial is open to the public. It was first published on May 3rd 2021 and has been amended as of September 21st 2022. 300 patients are expected to join from three separate sites." - Anonymous Online Contributor
How many participants have registered to partake in this experiment?
"That is correct. According to the clinicaltrials.gov website, this trial has been actively recruiting since May 3rd 2021 and was last modified on September 21st 2022. 300 participants are required from three sites for successful completion of this experiment." - Anonymous Online Contributor